Subscribe to FDA Safety Communications: Never Miss a Critical Alert
Nov 13 2025
Multiple System Atrophy (MSA-P) is a rare, aggressive neurological disorder with parkinsonian symptoms and severe autonomic failure. Unlike Parkinson’s, it progresses rapidly, responds poorly to treatment, and has a median survival of only 6-10 years.
Nov 13 2025
Sep 28 2025
Mar 25 2025
Nov 17 2025
Nov 25 2025